FDA Approves Zanvastro, First Treatment for Alexander Disease

The FDA has approved Zanvastro (zilganersen) injection, marking the first-ever treatment for Alexander disease. This novel therapy directly targets the underlying protein buildup causing this rare, progressive neurological disorder. The approval offers a new therapeutic option for both pediatric and adult patients suffering from this severe condition.